BCR and acute lymphoblastic leukemia: Although BCR::ABL1-positive B-ALL did not correlate with any specific marker (p = 0.34), all cases in this series exhibited at least one leukemia-associated immunophenotype (LAIP) suitable for MRD monitoring via flow cytometry (Supplementary Table S2).